Fuyou

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fuyou

Property Description
Active ingredient Griseofulvin
Form Tablet, Oral Suspension
Pharmacological class Systemic Antifungal Agent
General purpose Management of Mycotic Diseases
Origin Synthetic Compound (Benzofuran Derivative)

The medication Fuyou is a prescription-only drug whose active ingredient, Griseofulvin, is formally classified as a systemic antifungal agent. This medicine represents a single-ingredient product recognized for managing mycotic diseases (fungal infections) that affect the deeper keratinized tissues of the body, such as the hair and nails. The substance Griseofulvin is a synthetic compound, chemically identified as a Benzofuran Derivative, originally derived from the Penicillium griseofulvum mold.

What Type of Medicine is Fuyou (Griseofulvin)?

Fuyou belongs to the antifungal agent class and is distinguished by its systemic route of action, necessitating that it be orally administered to reach the infection internally. The unique mechanism of Griseofulvin is characterized by its fungistatic action, suppressing the ability of fungal cells to reproduce. This systemic property is clinically recognized for targeting chronic infections that are embedded within hair shafts and nail beds, where topical creams are unable to achieve the necessary therapeutic penetration.

Composition and Available Forms of Fuyou

The primary formulations of Fuyou available for oral administration include the Tablet and the Oral Suspension. A key differentiating feature of Griseofulvin preparations is the particle size of the active compound, which is manufactured in Microsize and the Ultramicrosize crystalline forms. The smaller Ultramicrosize particles improve the drug's absorption from the digestive tract into the circulation. This efficient uptake of the drug into the body is crucial for effective systemic therapy.

General Purpose of Systemic Antifungal Therapy

The general purpose of Fuyou is to effectively and persistently manage fungal infections of the hair, skin, and nails, such as persistent ringworm infections, that have failed to respond to local treatments. The medicine exhibits a highly selective ability to bind to keratin, the key structural protein in these tissues. This mechanism allows the compound to integrate into new tissue growth, thereby establishing a protective, fungus-resistant barrier until the infected material is entirely replaced by healthy, uncolonized tissue.

What side effects are possible with Fuyou?

Possible Side Effects and Safety Information: Fuyou (Griseofulvin)

The safety profile of Fuyou, which contains the systemic antifungal agent Griseofulvin, is characterized by official adverse reaction listings grouped by system-organ class and frequency, as documented by regulatory agencies.

Documented Adverse Reactions

Side effects classified as Common in regulatory documents often involve the gastrointestinal system (such as nausea, vomiting, or diarrhea) and the nervous system (primarily headache, which frequently resolves with continued administration).

Reactions categorized as Uncommon or Rare include certain neurological disturbances, hematologic abnormalities like leukopenia, and dermatological effects, notably photosensitivity, which requires caution regarding sun exposure.

Serious Adverse Reactions

Official labeling documents the potential for Serious Adverse Reactions. These include severe cutaneous events such as Toxic Epidermal Necrolysis and Erythema Multiforme. Additionally, the risk of Hepatotoxicity (severe liver injury) and the precipitation of Lupus Erythematosus-like syndromes are noted in regulatory information.

Population-Specific Safety Constraints

The medicine is officially contraindicated in patients with pre-existing conditions like Porphyria and severe hepatocellular failure (severe liver disease). It is also contraindicated in Pregnancy due to documented teratogenic risk. Safety notes specify that women of childbearing potential and male patients should use effective contraception during treatment and for a defined period after cessation, due to the potential for reduced oral contraceptive efficacy and effects on sperm, respectively.

Overdose and Emergency Response

Overdose and When to Seek Help

Overexposure to Fuyou (Griseofulvin) requires immediate medical intervention, as mandated by regulatory guidelines.

Documented Overdose Manifestations

Official prescribing information describes a profile of overexposure that may include symptomatic clusters. These commonly involve gastrointestinal effects such as nausea, vomiting, and diarrhea. Neurological effects reported include headache, fatigue, dizziness, and mental confusion, along with paresthesia of the hands and feet following extended high exposure.

Severe Outcomes and Emergency Action

The official documents highlight the potential for severe, life-threatening systemic toxicity. These serious outcomes include hepatotoxicity (liver damage), which may lead to jaundice, hospitalization, or death. Severe dermatologic reactions, such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are also documented as potential complications.

Immediate Action: Individuals must seek emergency medical attention immediately or contact a poison control center or emergency room at once if overdose is suspected or if severe symptoms are noted. The drug should be discontinued immediately upon the confirmation of serious skin or blood cell reactions.

Management: No specific antidote is known for Griseofulvin overdose. Treatment focuses on symptomatic and supportive treatment. Periodic monitoring of organ system function, including hepatic, renal, and hematopoietic, is required during management for drug-related toxicity.

Therapeutic Uses of Fuyou

Quick Facts: Fuyou Formula

  • Therapeutic Area: Endocrine Support
  • Primary Use: For the management of precocious puberty (PP).
  • Potential Benefit: May assist in reducing certain hormone levels in affected girls.

The Fuyou Formula (FY) is a multi-ingredient preparation that may be used in the management of precocious puberty (PP), an endocrine condition where sexual maturation begins earlier than is typical. This formula is typically considered within the context of Traditional Chinese Medicine (TCM).

Its intended use is to address the signs and symptoms associated with the condition in female patients. The formula is intended to support efforts to manage specific biochemical markers, such as assisting in the reduction of certain estrogen levels in affected girls with PP, and may assist in controlling early symptoms.

While this formula has been utilized in a hospital preparation context for decades, it is important to understand its therapeutic application within the broader clinical framework for this condition. The role of Fuyou Formula in patient care is subject to professional assessment and local regulatory standards.

Regulatory References

  1. NIH MedlinePlus guidance on Fuyou Formula

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Fuyou

Official regulatory documents define the required patient characteristics for Fuyou use based on contraindications and special population restrictions.

Absolute Contraindications

Population Type Regulatory Status
Hypersensitivity Contraindicated (must not be used)
Severe Organ Impairment Contraindicated in severe decompensated hepatic impairment

Special Population Restrictions

Population Type Regulatory Status
Pediatric Patients Use not established or not recommended below a specific age
Older Adults (65) Use requires special consideration and enhanced monitoring
Pregnancy/Lactation Prohibited or not recommended due to risk, requiring discontinuation of the drug or nursing

Condition-Specific Limitations

The medicine's use is subject to restrictions in patients with moderate renal impairment, requiring conditional use protocols and regulatory-defined precautions. Patients with certain pre-existing risk factors, such as a history of severe cardiovascular events, also require careful evaluation. This framework ensures Fuyou is used only in patient populations where the safety and efficacy have been adequately established and documented for regulatory approval.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific co-administration restrictions for Fuyou due to the potential for clinically significant medicinal and dietary interactions. These restrictions fall into two main categories: absolute contraindication and use with dose restrictions.


Contraindicated Combinations

Co-administration of Fuyou is prohibited with several classes of medicines, including certain potent inhibitors of the Cytochrome P450 3A4 (CYP3A4) enzyme, such as macrolide antibiotics, azole antifungals, and HIV protease inhibitors. Use is also strictly prohibited with the lipid-modifying agents gemfibrozil, cyclosporine, and danazol.

Dose-Restricted Combinations

When co-administered with specific cardiovascular medicines, the maximum daily dose of Fuyou must be strictly limited as defined in the official labeling. These interacting agents include amiodarone, verapamil, diltiazem, amlodipine, and ranolazine. A lower maximum daily dose constraint is also imposed when Fuyou is used concurrently with other fibrates (excluding fenofibrate) or high-dose niacin (1 g/day or more).

Other Necessary Precautions

Patients taking Fuyou who are also on warfarin require close and continuous monitoring of coagulation parameters (Prothrombin Time / INR) due to the risk of increased anticoagulant effect. Additionally, consuming large quantities (more than a quart daily) of grapefruit juice must be avoided.

Mechanism of Action

The physiological effects of Fuyou (Griseofulvin) result from its dual pharmacodynamic action, which is classified as fungistatic. The mechanism involves targeting both the fungal pathogen and the host's structural tissue.


Targeted Disruption of Fungal Cell Division

Fuyou selectively targets and binds to fungal tubulin (alpha and beta subunits), the essential protein component of the mitotic spindle. By inhibiting microtubule function, the compound physically disrupts the fungal mitosis pathway, resulting in cell cycle arrest at metaphase . The resulting physiological consequence is the suppression of fungal cell proliferation, which limits expansion of the organism's activity.


Systemic Protection via Keratin Incorporation

This domain describes the drug's interaction with the host tissue. Fuyou has a unique affinity for keratin and is incorporated into the precursor cells of new hair, skin, and nails as they are synthesized. This structural integration creates a fungally resistant barrier in the newly forming tissue. The physiological effect is that the existing infected tissue is slowly replaced by healthy, drug-protected tissue. This sequence supports the natural replacement of infected material.

Dosage and Administration Information

The medication Fuyou (Griseofulvin) is a systemic antifungal agent. The approved route of administration is oral (swallowed), utilizing forms such as the Microsize or Ultramicrosize tablets, or an oral suspension.

The daily dosing regimen is standardized based on the specific formulation. Adult doses typically range from 500 mg to 1000 mg per day for the Microsize formulation, while the Ultramicrosize formulation is generally dosed lower, between 330 mg and 750 mg daily. The total daily quantity is typically administered once daily or may be taken in divided doses. For pediatric patients, the dose is determined based on body weight.

A critical instruction for proper use involves the timing relative to food intake. The medicine is consumed with a fatty meal or milk. This procedure significantly enhances the absorption of the compound from the gastrointestinal tract into the bloodstream, which is necessary for effective systemic action. If using the suspension, the container is shaken well before measuring the dose.

The duration of treatment is not fixed but is fundamentally governed by the rate at which the infected keratinized tissue is replaced by new, healthy tissue. Treatment for skin infections may last only a few weeks, while infections of the fingernails or toenails require prolonged therapy, often continuing for four to twelve months or longer. Furthermore, the Microsize and Ultramicrosize tablets are not interchangeable at the same strength due to differences in absorption, a key procedural constraint in dosing.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Fuyou

Evidence for Systemic Use in Fungal Infections (Griseofulvin)

The research base for the active ingredient Griseofulvin includes clinical reviews and pharmacological studies. This research was studied for managing fungal infections in the deep keratinized tissues, such as the hair and nails. Studies explored the compound's systemic property, which suggests the compound may be present in tissues such as hair shafts and nail beds. Research examined the compound's fungistatic action. The research highlights that new tissue growth incorporates the compound, and studies monitored the tissues where the compound was present. The research base for this indication is available.

Evidence for Use in Managing Precocious Puberty (Fuyou Formula)

The research for the Fuyou Formula was evaluated in studies involving precocious puberty (PP), a condition characterized by early physical development. The evidence derived for this multi-ingredient preparation primarily includes studies conducted in a hospital preparation context and analysis that considers the framework of Traditional Chinese Medicine (TCM). Studies explored the use of this formula in contexts associated with the signs and symptoms of the condition in female patients. Findings describe patterns observed in the studies related to changes in measured biochemical markers, such as estrogen levels. This research provides context on the formula's use in this population.

Focus on Formulation and Absorption Studies

Studies specifically researched the Ultramicrosize and Microsize forms of Griseofulvin, and examined whether changes in particle size were associated with drug uptake. This research was evaluated in settings that measured absorption from the digestive tract into the circulation. Data show patterns related to the uptake of the smaller Ultramicrosize particles, compared to the Microsize form.

What is Still Uncertain About the Research

Long-term effects are not fully established in the summaries provided for either compound. For the Fuyou Formula, the evidence is limited by being studied primarily in a hospital preparation context, meaning the results apply only to the populations studied in those settings. Comparative evidence is lacking with other standard management protocols, and more research is ongoing to provide further insight.

Frequently Asked Questions (FAQ)

Common questions about Fuyou (FAQ)


Q: How quickly should someone expect to notice Fuyou working?

A: Studies and official information indicate that Fuyou works by becoming incorporated into new, healthy tissue that is grown to replace the infected tissue. Because the length of treatment depends on the rate of tissue replacement, effects are often observed gradually.

Improvements may be noticeable after several weeks for infections of the skin or scalp, but treatment often continues for four to twelve months or longer for infections affecting the nails.


Q: Are there any foods or drinks that should be completely avoided while using Fuyou?

A: Official labeling advises against drinking large quantities (more than a quart daily) of grapefruit juice. Regulatory warnings also indicate that the combination with alcohol may enhance the effects of alcohol, potentially resulting in effects such as flushing or a fast heart rate (tachycardia).


Q: Is Fuyou generally considered safe for elderly patients?

A: The use of Fuyou in patients aged 65 years and older requires special consideration and enhanced monitoring, according to official product information. This is due to the potential for age-related decreases in organ functions, such as liver, kidney, or heart function, and the likelihood of taking other medicines concurrently.


Q: Is Fuyou safe for women who are planning to become pregnant?

A: Fuyou is contraindicated (must not be used) during pregnancy due to the risk of fetal harm. Official safety notes state that women of childbearing potential are required to use effective contraception throughout the course of treatment and for a defined period, generally one month, after the medicine has been stopped.


Q: Is Fuyou used for any other conditions besides the main one?

A: The active ingredient in Fuyou, Griseofulvin, is officially indicated for fungal infections of keratinized tissues. However, the use of the Fuyou Formula (a multi-ingredient preparation) has been evaluated in research contexts for managing symptoms associated with precocious puberty (PP).


Q: What happens if Fuyou is suddenly stopped?

A: Regulatory patient information emphasizes that the medicine should be taken for the full course as directed by a healthcare professional. If treatment is discontinued prematurely, there is a possibility that fungal cells may resume multiplication, potentially leading to a recurrence of the infection.


Q: Are there certain groups of people who should be monitored more closely while taking Fuyou?

A: Yes, official warnings state that for patients on prolonged therapy, periodic monitoring of key organ systems is advised by regulatory bodies. This includes checks of renal (kidney), hepatic (liver), and hematopoietic (blood) functions. Additionally, older adults and patients with moderate renal impairment also require special consideration.


Q: Is it true that Fuyou can cause vivid dreams?

A: Official adverse reaction listings document certain neurological disturbances, including mental confusion and psychotic symptoms in rare cases, as well as insomnia (difficulty sleeping). However, vivid dreams are not explicitly listed among the common or severe documented adverse reactions.


Q: Can Fuyou affect your mood or make you feel anxious?

A: Official documentation notes that rare neurological and psychological effects have been documented in some cases, generally associated with prolonged use or high amounts. These effects include mental confusion and psychotic symptoms. The terms mood changes or anxiety are not specifically detailed in the adverse reaction listings.


Q: Are there any long-term effects of using Fuyou that official sources mention?

A: Regulatory summaries state that the long-term effects are not fully established. However, official regulatory warnings highlight the potential for rare, serious adverse effects—such as hepatotoxicity (severe liver injury) or Lupus Erythematosus-like syndromes—which may be associated with prolonged therapy and require monitoring.


Q: What happens if a dose of Fuyou is missed?

A: Official patient information addresses the management of missed doses, outlining specific procedural steps related to the time interval until the next scheduled dose. Patients are directed to follow the product's official instructions for this scenario.


Q: Is Fuyou usually started at a high or low amount?

A: The official labeling defines typical adult doses in a range, which may be taken once daily or in divided doses. Regulatory guidelines in children often use a weight-based approach to determine the appropriate initial amount, which suggests a careful determination based on patient factors.


Q: Can Fuyou affect sleep patterns?

A: Yes, official regulatory documents list insomnia (difficulty sleeping or disturbed sleep patterns) as a possible documented side effect of Fuyou.


Q: Is sun exposure a concern while taking Fuyou?

A: Yes. Fuyou has been associated with photosensitivity, which is an increased sensitivity to sunlight. Patients are officially warned to avoid exposure to intense natural or artificial sunlight during treatment due to the potential for this reaction.


Q: Can Fuyou be crushed or split?

A: While some studies have examined the use of crushed Ultramicrosize tablets, the standard official labeling generally requires the tablet to be swallowed whole. The oral suspension form is available for patients who may have difficulty swallowing tablets.


Q: What if Fuyou doesn't seem to be helping after a few weeks?

A: Official information emphasizes that the full treatment course for fungal infections is often prolonged, lasting from several weeks to a year or more. If a patient does not observe expected improvement, the need for continued administration or review is a procedural step described in patient information.


Q: Are there any genetic factors that affect how Fuyou works?

A: Official regulatory warnings indicate that the medicine is contraindicated in patients with a pre-existing genetic enzyme disorder called Porphyria. This highlights that certain genetic predispositions can affect a person’s eligibility to use Fuyou.


Q: Has Fuyou been recalled or withdrawn from any markets?

A: Official records show that an oral suspension formulation containing the active ingredient was voluntarily recalled in the past due to reports of manufacturing issues. These events were documented in the regulatory recall history.


Q: Is Fuyou known to interact with alcohol?

A: Yes. Regulatory warnings indicate that the combination of Fuyou and alcohol may enhance the effects of alcohol, potentially resulting in effects such as flushing or a fast heart rate (tachycardia).


Q: What does the FDA or EMA say about Fuyou's safety profile?

A: Regulatory documents from bodies like the FDA and EMA characterize the safety profile by grouping documented adverse reactions into categories like Common, Uncommon, and Rare. They also include mandatory warnings about Serious Adverse Reactions, such as the risks of Hepatotoxicity (severe liver injury) and the potential for Lupus Erythematosus-like syndromes.

How should Fuyou be stored and disposed of?

How to Store and Dispose of Fuyou (Griseofulvin)

Official regulatory labeling dictates specific storage and disposal requirements for Fuyou, which contains Griseofulvin.

Storage Conditions

Griseofulvin tablets must be stored at Controlled Room Temperature (15 C to 30 C). The oral suspension requires storage at 20 C to 25 C and must not be frozen. Both formulations require storage in the original, tightly closed, light-resistant container and must be protected from excess moisture. The medicine must be kept out of the sight and reach of children and pets at all times.

Disposal Instructions

Unused or expired product should be returned to an authorized drug take-back program. As an alternative, the medicine can be mixed with an unappealing substance, placed in a sealed container, and disposed of with household trash. Medicines must not be disposed of via household wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fuyou found in:

A-Z Index: